Evidence map›Paper›PMID 25394313›Full record

ReviewCurrent opinion in hematology2015

How methicillin-resistant Staphylococcus aureus evade neutrophil killing.

Mallary Greenlee-Wacker, Frank R DeLeo, William M Nauseef

Open access · greenAbstract readReview
In one paragraph

Review in Current opinion in hematology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 46 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Human neutrophilsImmunological reviews · 2023
    Review
  8. Dalbavancin Boosts the Ability of Neutrophils to Fight Methicillin-ResistantInternational journal of molecular sciences · 2023
    Article
  9. Bi-fluorescentFrontiers in immunology · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. The Bacterial Amyloids Phenol Soluble Modulins fromInternational journal of molecular sciences · 2021
    Article
  14. Article
  15. Innate Immunity toJournal of immunology (Baltimore, Md. : 1950) · 2018
    Review
  16. Article
  17. Article
  18. Mitochondrial quality control in alveolar epithelial cells damaged byAmerican journal of physiology. Lung cellular and molecular physiology · 2017
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

Mallary Greenlee-WackeraInflammation Program bDepartment of Internal Medicine, Roy J. and Lucille A. Carver College of Medicine, University of Iowa cVeterans Administration Medical Center, Iowa City, Iowa dLaboratory of Human Bacterial Pathogenesis, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA.
Frank R DeLeo
William M Nauseef
GTx (United States) · USNational Institute of Allergy and Infectious Diseases · USUniversity of Iowa · US

Funding

Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Brandi Janssen · 1990 to 2026
$40.5M
Studies of the capsular-like antigen of F. tularensisP01AI044642 · NIAID · UNIVERSITY OF IOWA · PI ALLEN, LEE-ANN H · 1999 to 2014
$18.2M
Mechanisms of Staphylococcus aureus virulenceZIAAI001079 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI DELEO, FRANK · 2009 to 2025
$11.8M
Consequences of interactions between human neutrophils and Staphylococcus aureusR01AI116546 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 2015 to 2019
$1.8M
Innate immune defense against community associated methicillin-resistant S.aureusR01AI070958 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 2008 to 2011
$1.3M
Innate immune defense against community associated methicillin-resistant S.aureusR56AI070958 · NIAID · UNIVERSITY OF IOWA · PI NAUSEEF, WILLIAM M. · 2013 to 2013
$355k
Human neutrophils, phospholipase A2 and S.aureus: microbial targets and responsesI01BX000513 · VA · IOWA CITY VA MEDICAL CENTER · PI NAUSEEF, WILLIAM M. · 2009 to 2017
–
BLRD VA I01 BX000513Intramural NIH HHSNIAID NIH HHS AI044642NIAID NIH HHS AI70958NIAID NIH HHS P01 AI044642NIAID NIH HHS R01 AI070958NIAID NIH HHS R01 AI116546NIAID NIH HHS R56 AI070958NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

purpose of reviewMethicillin-resistant strains of the important human pathogen Staphylococcus aureus pose a significant public health threat in the community, as they are easily transmitted, especially prone to cause invasive disease, and infect otherwise healthy individuals. The mechanistic basis for the ability of these organisms to evade the innate immune responses remains incompletely defined. RECENT

findingsThe success of pathogens such as S. aureus rests, in part, on their capacity to overcome neutrophil-mediated host defense to establish infection and cause human disease. S. aureus has the potential to thwart effective neutrophil chemotaxis, and phagocytosis, and succeeds in evading killing by neutrophils. Furthermore, S. aureus surviving within neutrophils promotes neutrophil cytolysis, with release of host-derived molecules that promote local inflammation. Here, we provide a brief overview of our understanding of the mechanisms by which S. aureus - including methicillin-resistant S. aureus - avoids neutrophil-mediated host defense and causes disease. SUMMARY: Understanding the molecular mechanisms by which S. aureus avoids neutrophil-mediated responses and initiates signaling cascades that culminate in neutrophil lysis will provide insights prerequisite to the development of novel targets for treating staphylococcal infections.

Indexed as

Immune EvasionPhagocytosisAnimalsChemotaxisHumansMethicillin-Resistant Staphylococcus aureusNeutrophilsStaphylococcal Infections

Identifiers

PMID25394313
PMCPMC4343318
OpenAlexW2314357788

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.